A Study of Niraparib in Patients with Ovarian Cancer in Clinical Practice
Not Applicable
Recruiting
- Conditions
- Ovarian Cancer
- Registration Number
- JPRN-jRCT2031210289
- Lead Sponsor
- Contact for Clinical Trial Information
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 300
Inclusion Criteria
An individual who corresponds to any of the following:
- Ovarian cancer patients after initial chemotherapy (maintenance therapy)
- Patients with platinum antineoplastic drug sensitive recurrent ovarian cancer (maintenance therapy)
- Recurrent ovarian cancer with platinum-sensitive homologous recombination repair defects.
Exclusion Criteria
Has a history of hypersensitivity to any of the ingredients of this drug.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method